The disappearance rate of Pregnancy-Associated Plasma Protein-A (PAPP-A) after the end of normal and abnormal pregnancies

Bischof P (1979) Purification and characterization of pregnancy-associated plasma protein-A (PAPP-A). Arch Gynecol 227: 315–326

Bischof P, Haenggeli L, Sizonenko MT, Herrmann WL, Sizonenko PC (1981) A radioimmunoassay for the measurement of pregnancy-associated plasma protein-A (PAPP-A) in humans. Biol Reprod 24: 1076–1081

Bischof P, Rapin CH, Weil A, Herrmann WL (1982a) Is pregnancy-associated plasma protein-A a tumor marker? Am J Obstet Gynecol 43: 379–381

Bischof P, Lauber K, Wurstemberger B de, Girard JP (1982b) Inhibition of lymphocyte transformation by pregnancy-associated plasma protein-A (PAPP-A). J Clin Lab Immunol 7: 61–65

Bischof P, DuBerg S, Herrmann WL, Sizonenko PC (1982c) Amniotic fluid and circulating levels of pregnancy-associated plasma protein-A (PAPP-A) throughout pregnancy. Comparison with other foeto-placental products. Br J Obstet Gynaecol 89: 358–363

Bischof P, Geinoz A, Herrmann WL, Sizonenko PC (1983a) Pregnancy-associated plasma protein-A (PAPP-A) specifically inhibits the third component of human complement. Placenta (in press)

Bischof P, Meisser A, Haenggeli L, Reber G, Bouvier C, Béguin F, Herrmann WL, Sizonenko PC (1983b) Pregnancy-associated plasma protein-A (PAPP-A) inhibits thrombin induced coagulation of plasma. Thromb Res 32: 45–55

Bischof P, DuBerg S, Sizonenko MT, Schindler AM, Béguin F, Herrmann WL, Sizonenko PC (1984) In vitro production of pregnancy-associated plasma protein-A (PAPP-A) by human decidua and trophoblast. Am J Obstet Gynecol 148: 913–920

DuBerg S, Bischof P, Schindler AM, Béguin F, Herrmann WL, Sizonenko PC (1982) Tissue and plasma concentrations of pregnancy-associated plasma protein-A (PAPP-A). Comparison with other foeto-placental products. Br J Obstet Gynaecol 89: 352–357

Folkersen J, Westergaard JG, Hindersson P, Teisner B (1979) Affinity chromatographic purification of a new high molecular weight pregnancy specific protein SP4. In: Lehmann FG (ed) Carcinoma-embryonic proteins, Vol II. Elsevier/North-Holland, Biomedical Press, pp 503–508

Folkersen J, Grudzinskas G, Hindersson P, Teisner B, Westergaard JG (1981) Pregnancy-associated plasma protein-A: Circulating levels during normal pregnancy. Am J Obstet Gynecol 139: 910–914

Lin TM, Halbert SP, Kiefer D, Spellacy WN (1974) Three pregnancy-associated human plasma proteins: purification, monospecific antisera and immunological identification. Int Arch Allergy Appl Immunol 47: 35–53

Segel IH (1975) Biochemical calculations. John Wileys and Sons Inc., New-York London Sydney Toronto, pp 225–233

Sinosich MJ, Davey MW, Ghosh P, Grudzinskas JG (1982) Specific inhibition of human granulocyte elastase by human pregnancy-associated plasma protein-A. Biochem Int 5: 777–786

Smith R, Bischof P, Hughes G, Klopper A (1979) Studies on pregnancy-associated plasma protein-A in the third trimester of pregnancy. Br J Obstet Gynaecol 86: 882–887

Sutcliffe RG, Kukulska-Langlands BM, Coggins JR, Hunter JB, Gore GH (1980) Studies on human pregnancy-associated plasma protein-A. Purification by affinity chromatography and structural comparison with α2-macroglobulin. Biochem J 191: 799–809